Romark Laboratories, L.C.

The people of Romark Laboratories share a passion for scientific discovery and a desire to make a difference in the world's health. Throughout all phases of drug discovery and development, Romark's people are teamed in a quest to provide new treatments for diseases that impact the lives of people worldwide.

Learn more

Romark Announces Final Data from Clinical Trial of Nitazoxanide in Treatment-naïve Patients with Genotype 1 Chronic Hepatitus C
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naïve patients...

Romark Announces Data from Clinical Trial of Nitazoxanide in Patients with Genotype 1 Chronic Hepatitis C Who Previously Failed Treatment with Peginterferon Plus Ribavirin
Romark Laboratories announced final results from its STEALTH C-2 clinical trial, a phase 2 clinical study of nitazoxanide....

More news